Your Cart
Your cart is empty

Looks like you haven't added any test / checkup to your cart

Add Test / Checkup
User Sign In Health checkup offers
Lab Test

Flow Cytometry in Monitoring T-ALL: MRD-T-ALL Panel

Flow Cytometry in Monitoring T-ALL: MRD-T-ALL Panel

T-cell Acute Lymphoblastic Leukemia (T-ALL) is a fast-growing type of blood cancer. It occurs when the bone marrow produces too many immature T-cells, a kind of white blood cell. The T-ALL landscape has seen significant advancements, with Minimal Residual Disease (MRD) emerging as a vital prognostic factor influencing treatment decisions.

  • Test NameFlow Cytometry in Monitoring T-ALL: MRD-T-ALL Panel
  • Sample TypeBone Marrow
  • Preparations RequiredNo specific preparation or fasting is needed for this test. Always inform your doctor about any medications or health issues before taking the test.
  • Report Time3 days

MRD refers to the minute number of cancer cells that might linger in the body during or after treatment, potentially leading to a relapse. The MRD-T-ALL Panel through Flow Cytometry helps in detecting these hidden cells, giving doctors a crucial edge in effectively managing T-ALL.

Home Sample Collection Process

Book your convenient slot
Book your convenient slot
Sample Collection by Phlebotomist
Sample Collection by Phlebotomist
Reporting of the sample at lab
Reporting of the sample at lab
Download Reports
Download Reports
Frequently Asked Questions

The MRD-T-ALL Panel is a diagnostic test that employs Flow Cytometry to detect minimal residual disease (MRD) in patients with T-cell Acute Lymphoblastic Leukemia (T-ALL).

There is no need for special preparation or fasting before this test. However, make sure to inform your doctor about any ongoing medications or health conditions.

The panel uses flow cytometry to examine specific cellular markers and assess the presence of minimal residual disease (MRD) - the remaining leukemia cells in the body during or after treatment.

The frequency of this test depends on your doctor's recommendation, based on factors such as the stage of your T-ALL, your health condition, and your treatment response.

The aim of T-ALL treatment is to achieve MRD negativity, implying no detectable residual leukemia cells. What is deemed 'normal' or 'negative' may vary based on the particular methods and technologies utilized in the test.

No special precautions are required for this test. But, it is vital to inform your doctor about any medications or supplements you're currently taking.

Factors such as the timing of the sample collection, the type of sample collected (blood or bone marrow), and the specific technology used for the test can influence the results. Your doctor will take these factors into account while interpreting the results.

If your MRD-T-ALL panel results are abnormal, consult a hematologist or oncologist. They can provide detailed information about the findings and guide you on the next steps.

The risks associated with this test are minimal and mainly relate to the sample collection process. These may include minor bleeding or infection at the puncture site. Serious complications are rare.

An abnormal result indicates the presence of minimal residual disease (MRD), suggesting that some leukemia cells may still be present in the body, even after treatment. This could signal a potential risk of relapse and may necessitate alterations in treatment.

Treatment options depend on various factors, including your overall health and the amount of residual disease. Options may include intensifying chemotherapy, immunotherapy, or considering a stem cell transplant. Your doctor will discuss the best approach for your case.

MRD-T-ALL is not preventable, but early detection and aggressive treatment of T-ALL can increase the chances of achieving MRD negativity and improve the prognosis.

Healthy lifestyle choices can contribute positively to overall health, boost your immune system, and improve your ability to cope with treatment and its side effects.

Pregnant women should consult their doctor before undergoing any tests. The doctor will consider the potential risks and benefits to both the mother and the baby.

No, the MRD-T-ALL Panel using Flow Cytometry does not involve radiation exposure.

Flowcytometry Panel - MRD - T-ALL
₹ 13500
Schedule Test in Your Available Time
Locations Near You in Hyderabad
  • 4KM from Madhapur
  • 3KM from Banjara Hills
  • 1.9KM from Yusufguda
  • 3KM from Madhura Nagar
  • 5KM from Shaikpet